Dr. Bridgitte Shen Lee

I am excited to share that I have been invited as one of the speakers for the upcoming 4th TFOS China & 8th National Cornea Innovation Conference! This event will take place from August 7–9, 2026, in the beautiful city of Kunming, China. I will be sharing our clinical experience on these two topics:

1. Improving Dry Eye Patient Understanding and Compliance
2. Utilizing Targeted Novel Pharmaceutical Treatment

Cannot wait to see these passionate and brilliant cornea specialists and eye care educators soon!

Thank you Tear Film & Ocular Surface Society (TFOS) and TFOS China for the opportunity to collaborate!

Photo: from the 2024 TFOS meeting in Venezia!

At our practice Vision Optique Optique, the theme for 2026’s DryEyeAwarenessMonth education is on .

Demodex Blepharitis is a pervasive and damaging eyelid disease, caused by an infestation of demodex mites. Left untreated, it contributes to significant dry eye and meibomian gland dysfunction symptoms.

We updated our patients with the latest pharmaceutical, in-office procedures, and at-home lids/lashes hygiene care treatment protocol:

1. Treat DB with FDA approved Rx eye drop: lotilaner ophthalmic solution 0.25% (Xdemvy), Tarsus Pharmaceuticals, Inc.
XDEMVY®

2. In-office exfoliating cleaning procedure: NuLids, with our new full time associate doctor Dr. Vanesa Flores.
NuLIDS
Vanesa Flores

3. At-home daily skin care:

- Èyes Are The Story face cleanser
Èyes Are The Story = Eye Safe Beauty
- SCOPE Eyecare hypochlorous acid spray
Scope Eyecare

Our patients appreciate these technology and products update and clear instructions!

October 24-25, 2025: Myopia Collective events at CooperVision Specialty Contact Lens HQ!
Honored to serve and to represent Texas!

Thank you American Academy of Optometry for accepting these posters and lecture! Have you registered to attend the 2026 meeting in Anaheim and
what topics are you presenting on?
Hope to see many of you in October!

Photo: on top of the Avatar mountain in China this past March. I love traveling whenever I can!


TFOS - Tear Film & Ocular Surface Society
Vision Optique

June 2026: enjoyed visiting colleague at Beijing TongRen eye hospital

Congratulations to Dr. Rolando Toyos and the planning committee on a very successful inaugural Dry Eye Society of the Americas ( ) meeting in NYC! On Saturday July 11, 32 topics on ocular surface and dry eye disease, nutrition and longevity were shared by passionate researchers, innovators, thought leaders, and clinicians from around the world. We all enjoyed learning across specialties, sharing ideas, and meeting new friends.

Thank you to all the industry sponsors for your support!

Repost

May is Healthy Vision Month!

Established in May 2003 by the National Eye Institute (NEI), this nationwide campaign raises awareness about the importance of scheduling routine eye exams, preventing avoidable vision loss, and adopting healthy lifestyle habits that protect long-term eye health. At our clinic, Vision Optique, evidence-based nutritional supplements are part of the daily conversation with our patients.

This new open-access review in Clinical Ophthalmology - “B Vitamins and Ocular Health” by Johnson, Poteet, Gioia, Maharaj, Benitez-del-Castillo, and Labetoulle - is an informative summary of the role of B Vitamins and eye health protection. The article offers patient-conversation reference, and helpful context for why a B-complex was added to the new PreserVision AREDS3 formula.

B vitamins (B1, 2, 3, 6, 9, 12) are crucial for ocular health. They support mitochondrial function, regulate homocysteine levels, and protect the optic nerve. Specific benefits include reducing Age-Related Macular Degeneration (AMD) risks, alleviating Dry Eye Disease (DED) symptoms, slowing cataract progression, and maintaining corneal health.

Repost

Age-related Macular Degeneration (AMD) is one of the most common ocular diseases in the US. It affects ~17% of US individuals >40 years of age, and it accounts for 15–20% of global blindness. Left untreated, it is a leading cause of irreversible vision loss in adults.

The original AREDS (Age-Related Eye Disease Study) vitamin formulation was published by the National Eye Institute (NEI) in 2001. Since then, new formulations based on subsequent research have been developed and brought to market with AREDS2 (August 2013), and AREDS3 (May 2026).

The new AREDS3 is a next generation formula for more complete AMD management that includes a B-Vitamin complex. Evidence to date supports B vitamins’ role in enhancing oxidative stress protection, cellular metabolism and healthy homocysteine levels, reducing the risk of visually significant AMD and early AMD.

These two open-access articles are a great read on overview of AMD and role of nutriceuticals, especially the addition of B-vitamin complex.

1. “Role of B Vitamins in Preventing the Development and Progression of Age-Related Macular Degeneration”

Drs. Poteet, Koetting, and Vakharia in Ophthalmology and Therapy. They review more than two decades of evidence on B vitamins and AMD — including the 34% risk reduction seen in the WAFACS RCT with B6/B9/B12. The mechanistic discussion of homocysteine and the RPE is especially well done, and it’s exciting to see this science now translated into the new PreserVision AREDS3 formulation.

2. “AREDS3 and multivitamin coadministration: practical safety, rationale, and clinical guidance for eye care professionals”

Drs. Poteet, Quint, and Kannarr in Optometry 360. This article on AREDS3 + multivitamin coadministration offers excellent references: clear nutrient-level safety considerations, a side-by-side with Centrum Silver, and a structured 4-step counseling approach.

Grateful to my mother and to be mama to my daughters ❤️
Happy Mother’s Day to all the amazing mothers and motherly figures who shape our families and communities with your patience, dedication, sacrifice, joy and unconditional love 💕

Photos with my daughters are from our spring break trip to the “Avatar Mountains” in ZhangJiaJie, China.